<?xml version="1.0" encoding="UTF-8"?>
<p>Ridostin is a drug based on dsRNA isolated from virus-like particles of the 
 <italic>Saccharomyces cerevisiae</italic> killer strain as two individual forms, L and M (4.6 kb and 1.8−1.6 kb, respectively) [
 <xref ref-type="bibr" rid="CR52">52</xref>]. It has been developed at the SRC VB “Vector” (Russia). Ridostin is a highly effective antiviral agent, an IFN inducer and an immunomodulator, which is used to treat influenza, herpes, and Chlamydia infection. Certain evidence exists that Ridostin increases the effectiveness of the antitumor therapy [
 <xref ref-type="bibr" rid="CR53">53</xref>].
</p>
